FDA Inspection
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited – FDA Inspection, Mar 9, 2011
Record Details
This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on March 9, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 9, 2011
- Product Type
- Biologics
View Company Profile
ID · b676ef63-86fc-41ac-b4ba-b631199b3f88
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 712228
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Takeda Pharmaceutical Company Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 14, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 11, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Takeda Pharmaceutical Company Limited
- FDA Inspection 1099764 - 2019-07-30
- FDA Inspection 975877 - 2016-06-15
- FDA Inspection 934717 - 2015-07-09
- FDA Inspection 844248 - 2013-08-14
- FDA Inspection 599120 - 2009-06-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.